MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors

Expert Opinion on Biological Therapy

Volumn 11, Issue 2, 2011, Pages 145-155

  Tazawa, Hiroshi ^a,b   Kagawa, Shunsuke ^b   Fujiwara, Toshiyoshi ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

cancer; gastrointestinal tumor; gene therapy; microRNA

Indexed keywords

ACETYLSALICYLIC ACID; ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; CURCUMIN; MICRORNA; MICRORNA 143 145; MICRORNA 17 92; MICRORNA 192; MICRORNA 194; MICRORNA 21; MICRORNA 215; MICRORNA 34; MICRORNA 7; ONCOLYTIC ADENOVIRUS; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P53; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN 53; STAT3 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GENE THERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE ARREST; CELL DIFFERENTIATION; COLON CARCINOGENESIS; DOWN REGULATION; GASTROINTESTINAL TUMOR; GENE EXPRESSION; GENE TARGETING; GLIOMA; HUMAN; INTESTINE EPITHELIUM; LUNG NON SMALL CELL CANCER; NONHUMAN; REVIEW;

ANIMALS; GASTROINTESTINAL NEOPLASMS; GENE THERAPY; HUMANS; MICRORNAS;

EID: 78651346918     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.542749     Document Type: Review

References (100)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
2. Lu J, Getz G, Miska EA, et al MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8
3. Volinia S, Calin GA, Liu CG, et al A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-61
4. Aguo J, Miao Y, Xiao B, et al Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hapatol 2009;24:652-7
5. Katada T, Ishiguro H, Kuwabata Y, et al microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009;34:537-42
6. Michael MZ, OConnor SM, van Holst Pellekaan NG, et al Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91
7. Bandres E, Cubedo E, Agirre X, et al Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29
8. Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mut Res 2010: published online 21 ma 2010, doi:10.1016/j.mrgentox.2010.05.006
9. Si ML, Zhu S, Wu H, et al miR-21-mediated tumor growth. Oncogene 2007;26:2799-803
10. Gregory PA, Bert AG, Paterson EL, et al The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601
11. Cimmino A, Calin GA, Fabbri M, et al miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-9
12. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34 induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472-7
13. McLin VA, Henning SJ, Jamrich M. The role of the visceral mesoderm in the development of the gastrointestinal tract. Gastroenterology 2009;136:2074-91
14. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005;132:4653-62
15. Hino K, Tsuchiya K, Fukao T, et al Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 2008;14:1433-42
16. McKenna LB, Schug J, Vourekas A, et al MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010;39:1654-64
17. Braun CJ, Zhang X, Savelyeva I, et al P53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008;68:10094-104
18. Geoges SA, Biery MC, Kim SY, et al Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 2008;68:10105-12
19. Song B, Wang Y, Kudo K, et al miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008;14:8080-6
20. Gartel AL, Serfas MS, Gartel M, et al p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 1996;227:171-81
21. Nguyen HT, Dalmasso G, Yan Y, et al MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem 2010;285:1479-89
22. Yan Y, Vasudevan S, Nguyen HT, Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim Biophys Acta 2008;1780:1087-92
23. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704-14
24. He L, He X, Lim LP, et al A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-4
25. Raver-Shapira N, Marciano E, Meiri E, et al Transcriptional activation of miR-34 contributes to p53-mediated apoptosis. Mol Cell 2007;26:731-43
26. Chang TC, Wentzel EA, Kent OA, et al Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745-52
27. Bommer GT, Gerin I, Feng Y, et al P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298-307
28. Tamura G, Kihana T, Nomura K, et al Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991;51:3056-8
29. Renault B, van den Broek M, Fodde R, et al Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 1993;53:2614-17
30. Kastrinakis WV, Ramchurren N, Rieger KM, et al Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 1995;11:647-52
31. Sano T, Tsujino T, Yoshida K, et al Frequent loss of heterozygosity on chromosome 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991;51:2926-31
32. Khine K, Smith DR, Goh HS. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer 1994;73:28-35
33. Risio M, Casorzo L, Chiecchio L, et al Deletions of 17p are associated with transition from early to advanced colorectal cancer. Cancer Genet Cytogenet 2003;147:44-9
34. Lodygin D, Tarasov V, Epanchintsev A, et al Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008;7:2591-600
35. Toyota M, Suzuki H, Sasaki Y, et al Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 isassociated with CpG island methylation in colorectal cancer. Cancer Res 2008;68:4123-32
36. Calin GA, Sevignani C, Dumitru CD, et al Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004
37. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, et al Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999;79:1468-74
38. Tenesa A, Farrington SM, Prendergast JG, et al Genome-wide association scan idenitifies a colorectal cancer susceptibility locus 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008;40:631-7
39. Welch C, Chen Y, Stallings RL. MicroRNA-34 functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007;26:5017-22
40. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421-6
41. Sun F, Fu H, Liu Q, et al Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008;582:1564-8
42. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010;17:193-9
43. Iio A, Nakagawa Y, Hirata I, et al Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 2010;9:136
44. Takagi T, Iio A, Nakagawa Y, et al Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009;77:12-21
45. Michael MZ, OConnor SM, van Holst Pellekaan NG, et al Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91
46. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007;26:311-20
47. Wang CJ, Zhou ZG, Wang L, et al Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009;26:27-34
48. Suzuki HI, Yamagata K, Sugimoto K, et al Modulation of microRNA processing by p53. Nature 2009;460:529-33
49. Sachdeva M, Zhu S, Wu F, et al p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009;106:3207-12
50. Chen, X, Guo X, et al Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009;28:1385-92
51. Ng EK, Tsang WP, Ng SS, et al MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009;101:699-706
52. Shi B, Sepp-Lorenzino L, Prisco M, et al MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007;282:32582-90
53. La Rocca G, Badin M, Shi B, et al Mechanism of growth inhibition by microRNA 145: the role of the IGF-I receptor signaling pathway. J Cell Physiol 2009;220:485-91
54. Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010;70:378-87
55. Gregersen LH, Jacobsen AB, Frankel LB, et al MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010;5:e8836
56. Chan SH, Wu CW, Li AF, et al miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008;28:907-11
57. Guo J, Miao Y, Xiao B, et al Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009;24:652-7
58. Zhang Z, Li Z, Gao C, et al miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008;88:1358-66
59. Li X, Zhang Y, Zhang Y, et al Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2010;59:579-85
60. Motoyama K, Inoue H, Mimori K, et al Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 2010;36:1089-95
61. Schetter AJ, Leung SY, Sohn JJ, et al MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-36
62. Schetter AJ, Nguyen GH, Bowman ED, et al Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 2009;15:5878-87
63. Iliopoulos D, Jaeger SA, Hirsch HA, et al STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010;39:493-506
64. Lin J, Jin X, Rothman K, et al Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Cancer Res 2002;62:376-80
65. Lu Z, Liu M, Stribinskis V, et al MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008;27:4373-9
66. Wang P, Zou F, Zhang X, et al microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009;69:8157-65
67. Lanza G, Ferracin M, Gafa R, et al mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007;6:54
68. Monzo M, Navarro A, Bandres E, et al Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 2008;18:823-33
69. Koizumi Y, Tanaka S, Mou R, et al Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin Cancer Res 1997;3:1067-76
70. Neklason DW, Tuohy TM, Stevens J, et al Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer. J Med Genet 2010;47:692-9
71. ODonnell KA, Wentzel EA, Zeller KI, et al c-Myc-regulated microRNAsmodulate E2F1 expression. Nature 2005;435:839-43
72. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007;282:2130-4
73. Yan HL, Xue G, Mei Q, et al Repression of the miR-17-92 cluster by p53 has an important funvtion in hypoxia-induced apoptosis. EMBO J 2009;28:2719-32
74. Olive V, Jiang I, He L. miR-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010;42:1348-54
75. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnosis and monitor diseases. Exp Opin Biol Ther 2009;9:703-11
76. Tsujiura M, Ichikawa D, Komatsu S, et al Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102:1174-9
77. Zhou H, Guo JM, Lou YR, et al Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 2010;88:709-17
78. Ng EK, Chong WW, Jin H, et al Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-81
79. Link A, Balaguer F, Shen Y, et al Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 2010;19:1766-74
80. Ohashi M, Kanai F, Ueno H, et al Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut 1999;44:366-71
81. Tatebe S, Matsuura T, Endo K, et al Adenovirus-mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells. Int J Oncol 1999;15:229-35
82. Spitz FR, Nguyen D, Skibber JM, et al In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res 1996;16:3415-22
83. Bouvet M, Ellis LM, Nishizaki M, et al Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 1998;58:2288-92
84. Shao J, Fujiwara T, Kadowaki Y, et al Overexpression of the wild-type p53 gene inhibits NF-kB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene 2000;19:726-36
85. Fujiwara T, Tanaka N, Kanazawa S, et al Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer. J Clin Oncol 2006;24:1689-99
86. Nemunaitis J, Swisher SG, Timmons T, et al Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 2000;18:609-22
87. Swisher SG, Roth JA, Nemunaitis J, et al Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 1999;91:763-71
88. Sakai R, Kagawa S, Yamasaki Y, et al Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer. Mol Cancer Ther 2010;9:1884-93
89. Van Beusechem VW, van den Doel PB, Grill J, et al Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency. Cancer Res 2002;62:6165-71
90. Ji Q, Hao X, Meng Y, et al Restoration of tumor suppresor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008;8:266
91. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-68
92. Ji Q, Hao X, Zhang M, et al MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009;4:e6816
93. Guessous F, Zhang Y, Kofman A, et al microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010;9:1031-6
94. Ali S, Ahmad A, Banerjee S, et al Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 2010;70:3606-17
95. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Imuunol 2003;171:3863-71
96. Corsten MF, Miranda R, Kasmieh R, et al MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007;67:8994-9000
97. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-6
98. Ma L, Reinhardt F, Pan E, et al Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010;28:341-7
99. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67
100. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009;8:102